Cutaneous T Cell Lymphoma: Clinical Trials

2 trials for Cutaneous T Cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Cutaneous T Cell Lymphoma: new trials by email Literature Review of Cutaneous T Cell Lymphoma trials Research Report on Cutaneous T Cell Lymphoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma
oral glucose tolerance test (OGTT) - Hypertriglyceridemia, Cutaneous T Cell Lymphoma
Phase 4CompletedRennes University Hospital102012-01-012017-07-21
Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A
Methoxsalen+ECP - Cutaneous T Cell Lymphoma, Mycosis Fungoides
Phase 4CompletedM.D. Anderson Cancer Center72004-04-022018-08-17

Narrower conditions

Lymphoma, T-Cell, Cutaneous (2)  ·  Hypertriglyceridemia (1)  ·  Mycosis Fungoides (1)

Broader conditions

Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Lymphatic Diseases (2)  ·  Lymphoma (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Lymphoma, T-Cell (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Dyslipidemias (1)  ·  Hyperlipidemias (1)  ·  Lipid Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Glucose Tolerance Test (1)  ·  Methoxsalen (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  Rennes University Hospital (1)

Countries

France (1)  ·  United States (1)

Top investigators

Madeleine Duvic, MD (1)

Results publications

PMID 21575927